CIK 0001806952
- Non-accelerated filer
- Smaller reporting company
Lyell Immunopharma, Inc.
Sign in to watch- Ticker
- LYEL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 833006753
- Phone
- +1 650-695-0677
- Business address
- 201 HASKINS WAY, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $49,999,983
- in 2 filings
- Open-market sales, last 90 days
- $215,781
- in 9 filings
Net +$49,784,202. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 41 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-10 | Bulis Veronica Sanchez VP, Corporate Controller | Grant or award | +8,750 | 15,891 | ||
| 2026-02-10 | Bulis Veronica Sanchez VP, Corporate Controller | Sale | −254 | $23.12 | $6K | 15,637 |
| 2026-02-10 | Shook David Chief Medical Officer | Grant or award · Option (right to buy) | +50,000 | 50,000 | ||
| 2026-02-10 | Lee Gary K. Chief Scientific Officer | Sale | −147 | $23.12 | $3K | 18,609 |
| 2026-02-10 | Lee Gary K. Chief Scientific Officer | Grant or award · Option (right to buy) | +50,000 | 50,000 | ||
| 2026-02-10 | Hill Stephen J. Chief Operating Officer | Sale | −109 | $23.12 | $3K | 19,031 |
| 2026-02-10 | Hill Stephen J. Chief Operating Officer | Grant or award · Option (right to buy) | +65,000 | 65,000 | ||
| 2026-02-10 | Meltz Mark A General Counsel | Grant or award · Option (right to buy) | +50,000 | 50,000 | ||
| 2026-02-10 | Seely Lynn President and CEO | Sale | −438 | $23.12 | $10K | 81,721 |
| 2026-02-10 | Seely Lynn President and CEO | Grant or award · Option (right to buy) | +155,000 | 155,000 | ||
| 2026-02-09 | Lee Gary K. Chief Scientific Officer | Grant or award | +4,000 | 18,756 | ||
| 2026-02-09 | Hill Stephen J. Chief Operating Officer | Grant or award | +4,000 | 19,140 | ||
| 2026-02-09 | Seely Lynn President and CEO | Grant or award | +20,000 | 82,159 | ||
| 2025-12-30 | Bulis Veronica Sanchez VP, Corporate Controller | Sale | −936 | $32.32 | $30K | 7,141 |
| 2025-12-24 | Bulis Veronica Sanchez VP, Corporate Controller | Sale | −1,136 | $38.67 | $44K | 8,077 |
| 2025-11-10 | Bulis Veronica Sanchez VP, Corporate Controller | Sale | −239 | $16.10 | $4K | 9,213 |
| 2025-11-10 | Lee Gary K. Chief Scientific Officer | Sale | −138 | $16.16 | $2K | 15,366 |
| 2025-11-10 | Hill Stephen J. Chief Operating Officer | Sale | −95 | $16.12 | $2K | 15,750 |
| 2025-11-10 | Seely Lynn President and CEO | Sale | −412 | $16.11 | $7K | 67,159 |
| 2025-10-27 | Lee Gary K. Chief Scientific Officer | Grant or award · Option (right to buy) | +68,000 | 68,000 |
Page 3 of 8 · 156 trades